ID

30259

Descrizione

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00527735

collegamento

https://clinicaltrials.gov/show/NCT00527735

Keywords

versioni (1)
  1. 25/05/18 25/05/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

25 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Lung Cancer NCT00527735

Inglese

Eligibility Lung Cancer NCT00527735

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed lung cancer (stage iiib/iv nonsmall-cell lung cancer or extensive stage small-cell lung cancer [sclc])
Descrizione

Carcinoma of lung | Non-Small Cell Lung Carcinoma TNM clinical staging | Small cell lung cancer extensive stage

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0684249
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C3258246
UMLS CUI [3]
C0278726
measurable tumor lesion (as long as it is not located in a previously irradiated area) as defined by modified world health organization criteria
Descrizione

Measurable Disease | Exception Irradiation Area Previous

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1522449
UMLS CUI [2,3]
C0005902
UMLS CUI [2,4]
C0205156
eastern cooperative oncology group performance status of ≤1 at study entry
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
accessible for treatment and follow-up
Descrizione

Accessibility Therapeutic procedure | Accessibility Follow-up

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0814423
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0814423
UMLS CUI [2,2]
C3274571
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
brain metastases
Descrizione

Metastatic malignant neoplasm to brain

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
malignant pleural effusion
Descrizione

Pleural Effusion, Malignant

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0080032
autoimmune disease
Descrizione

Autoimmune Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
motor neuropathy of autoimmune origin
Descrizione

Motor neuropathy Origin Autoimmune process

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0235025
UMLS CUI [1,2]
C0439659
UMLS CUI [1,3]
C0443146
sclc-related paraneoplastic syndromes
Descrizione

Paraneoplastic Syndromes Relationship Small cell carcinoma of lung

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030472
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0149925
any concurrent malignancy other than nonmelanoma skin cancer; carcinoma in situ of the cervix or breast; or prostate cancer treated with systemic therapy (participants with a previous malignancy but without evidence of disease for 5 years were allowed to enter the study)
Descrizione

Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of female breast | Exception Systemic therapy Prostate carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0686288
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1515119
UMLS CUI [5,3]
C0600139
prior systemic therapy for lung cancer. prior radiation therapy or locoregional surgeries performed later than at least 3 weeks prior to randomization date were allowed.
Descrizione

Systemic therapy Carcinoma of lung | Prior radiation therapy allowed | Operative Surgical Procedures Locoregional Previous allowed

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0684249
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C1947913
UMLS CUI [3,3]
C0205156
UMLS CUI [3,4]
C0683607
grade 2 peripheral neuropathy (motor or sensory)
Descrizione

Peripheral motor neuropathy CTCAE Grades | Sensory neuropathy CTCAE Grades

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0235025
UMLS CUI [1,2]
C1516728
UMLS CUI [2,1]
C0151313
UMLS CUI [2,2]
C1516728
known hiv or hepatitis b or c infection
Descrizione

HIV Infection | Hepatitis B | Hepatitis C

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
chronic use of immunosuppressants and/or systemic corticosteroids (used in the management of cancer or noncancer-related illnesses). however, use of corticosteroids was allowed if used as premedication for paclitaxel infusion or for treating immune-related adverse events or adrenal insufficiencies.
Descrizione

Immunosuppressive Agents chronic | CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Paclitaxel Infusion | Exception Adverse event Relationship Immune system | Exception Adrenal Insufficiency Adverse Event

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021081
UMLS CUI [1,2]
C0205191
UMLS CUI [2]
C3653708
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0144576
UMLS CUI [3,3]
C0574032
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0877248
UMLS CUI [4,3]
C0439849
UMLS CUI [4,4]
C0020962
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1963059
inadequate hematologic function defined by an absolute neutrophil count <1,500/mm^3, a platelet count <100,000/mm^3, or hemoglobin level <9 g/dl.
Descrizione

Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
inadequate hepatic function defined by a total bilirubin level >2.0 times the upper limit of normal (uln), or ≥2.5 times the uln if liver metastases are present, aspartate aminotransferase and alanine aminotransferase levels ≥2.5 times the uln or
Descrizione

Liver function Inadequate | Elevated total bilirubin | Relationship Secondary malignant neoplasm of liver | Aspartate aminotransferase increased | Alanine aminotransferase increased

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0741494
UMLS CUI [3,1]
C0439849
UMLS CUI [3,2]
C0494165
UMLS CUI [4]
C0151904
UMLS CUI [5]
C0151905
≥5 times the uln if liver metastases are present.
Descrizione

Aspartate aminotransferase increased | Alanine aminotransferase increased | Relationship Secondary malignant neoplasm of liver

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C0439849
UMLS CUI [3,2]
C0494165
inadequate renal function defined by a serum creatinine level ≥2.5 times the uln
Descrizione

Renal function Inadequate | Serum creatinine raised

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0700225
inadequate creatinine clearance defined as less than 50 ml/min.
Descrizione

Creatinine clearance Inadequate

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0812399
UMLS CUI [1,2]
C0205412
Ritorna all'inizio della pagina

Similar models

Eligibility Lung Cancer NCT00527735

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma of lung | Non-Small Cell Lung Carcinoma TNM clinical staging | Small cell lung cancer extensive stage
Item
histologically or cytologically confirmed lung cancer (stage iiib/iv nonsmall-cell lung cancer or extensive stage small-cell lung cancer [sclc])
boolean
C0684249 (UMLS CUI [1])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0278726 (UMLS CUI [3])
Measurable Disease | Exception Irradiation Area Previous
Item
measurable tumor lesion (as long as it is not located in a previously irradiated area) as defined by modified world health organization criteria
boolean
C1513041 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C0005902 (UMLS CUI [2,3])
C0205156 (UMLS CUI [2,4])
ECOG performance status
Item
eastern cooperative oncology group performance status of ≤1 at study entry
boolean
C1520224 (UMLS CUI [1])
Accessibility Therapeutic procedure | Accessibility Follow-up
Item
accessible for treatment and follow-up
boolean
C0814423 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0814423 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
Pleural Effusion, Malignant
Item
malignant pleural effusion
boolean
C0080032 (UMLS CUI [1])
Autoimmune Disease
Item
autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Motor neuropathy Origin Autoimmune process
Item
motor neuropathy of autoimmune origin
boolean
C0235025 (UMLS CUI [1,1])
C0439659 (UMLS CUI [1,2])
C0443146 (UMLS CUI [1,3])
Paraneoplastic Syndromes Relationship Small cell carcinoma of lung
Item
sclc-related paraneoplastic syndromes
boolean
C0030472 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0149925 (UMLS CUI [1,3])
Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Carcinoma in situ of female breast | Exception Systemic therapy Prostate carcinoma
Item
any concurrent malignancy other than nonmelanoma skin cancer; carcinoma in situ of the cervix or breast; or prostate cancer treated with systemic therapy (participants with a previous malignancy but without evidence of disease for 5 years were allowed to enter the study)
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0686288 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C1515119 (UMLS CUI [5,2])
C0600139 (UMLS CUI [5,3])
Systemic therapy Carcinoma of lung | Prior radiation therapy allowed | Operative Surgical Procedures Locoregional Previous allowed
Item
prior systemic therapy for lung cancer. prior radiation therapy or locoregional surgeries performed later than at least 3 weeks prior to randomization date were allowed.
boolean
C1515119 (UMLS CUI [1,1])
C0684249 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0543467 (UMLS CUI [3,1])
C1947913 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
Peripheral motor neuropathy CTCAE Grades | Sensory neuropathy CTCAE Grades
Item
grade 2 peripheral neuropathy (motor or sensory)
boolean
C0235025 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0151313 (UMLS CUI [2,1])
C1516728 (UMLS CUI [2,2])
HIV Infection | Hepatitis B | Hepatitis C
Item
known hiv or hepatitis b or c infection
boolean
C0019693 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Immunosuppressive Agents chronic | CORTICOSTEROIDS FOR SYSTEMIC USE | Exception Paclitaxel Infusion | Exception Adverse event Relationship Immune system | Exception Adrenal Insufficiency Adverse Event
Item
chronic use of immunosuppressants and/or systemic corticosteroids (used in the management of cancer or noncancer-related illnesses). however, use of corticosteroids was allowed if used as premedication for paclitaxel infusion or for treating immune-related adverse events or adrenal insufficiencies.
boolean
C0021081 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C3653708 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0144576 (UMLS CUI [3,2])
C0574032 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0877248 (UMLS CUI [4,2])
C0439849 (UMLS CUI [4,3])
C0020962 (UMLS CUI [4,4])
C1705847 (UMLS CUI [5,1])
C1963059 (UMLS CUI [5,2])
Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
inadequate hematologic function defined by an absolute neutrophil count <1,500/mm^3, a platelet count <100,000/mm^3, or hemoglobin level <9 g/dl.
boolean
C0221130 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Liver function Inadequate | Elevated total bilirubin | Relationship Secondary malignant neoplasm of liver | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
inadequate hepatic function defined by a total bilirubin level >2.0 times the upper limit of normal (uln), or ≥2.5 times the uln if liver metastases are present, aspartate aminotransferase and alanine aminotransferase levels ≥2.5 times the uln or
boolean
C0232741 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0741494 (UMLS CUI [2])
C0439849 (UMLS CUI [3,1])
C0494165 (UMLS CUI [3,2])
C0151904 (UMLS CUI [4])
C0151905 (UMLS CUI [5])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Relationship Secondary malignant neoplasm of liver
Item
≥5 times the uln if liver metastases are present.
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C0439849 (UMLS CUI [3,1])
C0494165 (UMLS CUI [3,2])
Renal function Inadequate | Serum creatinine raised
Item
inadequate renal function defined by a serum creatinine level ≥2.5 times the uln
boolean
C0232804 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0700225 (UMLS CUI [2])
Creatinine clearance Inadequate
Item
inadequate creatinine clearance defined as less than 50 ml/min.
boolean
C0812399 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial